Your browser doesn't support javascript.
loading
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy.
Abu-Raddad, Laith J; Chemaitelly, Hiam; Coyle, Peter; Malek, Joel A; Ahmed, Ayeda A; Mohamoud, Yasmin A; Younuskunju, Shameem; Ayoub, Houssein H; Al Kanaani, Zaina; Al Kuwari, Einas; Butt, Adeel A; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Shaik, Riyazuddin Mohammad; Abdul Rahim, Hanan F; Nasrallah, Gheyath K; Yassine, Hadi M; Al Kuwari, Mohamed Ghaith; Al Romaihi, Hamad Eid; Al-Thani, Mohamed H; Al Khal, Abdullatif; Bertollini, Roberto.
Afiliación
  • Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Chemaitelly H; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar.
  • Coyle P; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, United States.
  • Malek JA; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Ahmed AA; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar.
  • Mohamoud YA; Hamad Medical Corporation, Doha, Qatar.
  • Younuskunju S; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Ayoub HH; Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Al Kanaani Z; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Al Kuwari E; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Butt AA; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Jeremijenko A; Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar.
  • Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar.
  • Latif AN; Hamad Medical Corporation, Doha, Qatar.
  • Shaik RM; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, United States.
  • Abdul Rahim HF; Hamad Medical Corporation, Doha, Qatar.
  • Nasrallah GK; Hamad Medical Corporation, Doha, Qatar.
  • Yassine HM; Hamad Medical Corporation, Doha, Qatar.
  • Al Kuwari MG; Hamad Medical Corporation, Doha, Qatar.
  • Al Romaihi HE; Hamad Medical Corporation, Doha, Qatar.
  • Al-Thani MH; College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
  • Al Khal A; Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  • Bertollini R; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.
EClinicalMedicine ; 35: 100861, 2021 May.
Article en En | MEDLINE | ID: mdl-33937733
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: EClinicalMedicine Año: 2021 Tipo del documento: Article País de afiliación: Qatar
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: EClinicalMedicine Año: 2021 Tipo del documento: Article País de afiliación: Qatar